In particular, both PL-MSCs and their EVs promoted fusion and differentiation of human muscle cells from DMD patients, as well as decreased the expression of TGF-β and thus the fibrogenic differentiation of DMD myoblasts. The gene discussed is TGFB1; the disease is Duchenne muscular dystrophy.